Join our $10M Gains for Good challenge!

Daffy

Institute for Clinical and Economic Review

Institute for Clinical and Economic Review

Boston, MA 02109
Tax ID46-3250612

Want to make a donation using Daffy?

Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.

Payment method

Frequency

Amount

$USD
Daffy covers all ACH transaction fees so 100% of your donation goes to your favorite charities.

Do you work for Institute for Clinical and Economic Review? Learn more here.

By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.

About this organization

Revenue

$2,104,041

Expenses

$6,300,984

Website

icer.org

Mission

ICER is an independent and non-partisan research organization that objectively evaluates the clinical and economic value of prescription drugs, medical tests, and other health care innovations. Engaging with all key stakeholders -- including patients, doctors, life science companies and insurers -- ICER rigorously analyzes the clinical and economic data, and convenes public meetings to help translate evidence into policy decisions that lead to a more effective, efficient and just health care system. ICER’s drug assessment reports include a full analysis of how well each new drug works, the economic value each treatment represents, and other elements of value that are important to patients and their families.

About

The Midwest Comparative Effectiveness Public Advisory Council (Midwest CEPAC), a core program of the Institute for Clinical and Economic Review (ICER), is a nationally-recognized community forum. The Midwest CEPAC convenes multiple times each year at public meetings to appraise objective evidence reports, take public votes on the clinical and economic value of health care interventions, and develop recommendations for how stakeholders can apply evidence to improve the quality and value of health care.

Interesting data from their 2020 990 filing

The purpose of the non-profit is outlined in the filing as “Fair pricing, fair patient access, and future innovation.”.

When discussing its operations, they were defined as: “See schedule o”.

  • The state where the non-profit operates has been legally reported as CA.
  • The filing indicates that the non-profit's address in 2020 is located at TWO LIBERTY SQUARE NINTH FLOOR, BOSTON, MA, 02109.
  • The non-profit has reported 35 employees on their form as of 2020.
  • Is not a private foundation.
  • Expenses are greater than $1,000,000.
  • Revenue is greater than $1,000,000.
  • Revenue less expenses is -$4,196,943.
  • The organization has 10 independent voting members.
  • The organization was formed in 2013.
  • The organization pays $3,696,729 in salary, compensation, and benefits to its employees.
  • The organization pays $62,587 in fundraising expenses.